Resumen

MARQUES, Rui et al. Coronamellitus: An Infecto-Metabolic Pandemic. Medicina Interna [online]. 2020, vol.27, n.3, pp.33-37. ISSN 0872-671X.  https://doi.org/10.24950/O/119/20/3/2020.

Introduction: There are considerable differences in mortality due to SARS-CoV-2 infection. Advanced age and comorbidities, such as diabetes mellitus, have been associated with a worse prognosis. The aim of this study was to assess the impact of diabetes and metabolic control on Emergency Department (ED) admission in patients with COVID-19 with hospitalization criteria. Methods: Clinical and laboratorial features were assessed through ED clinical file consultation of patients hospitalized with COVID-19 at CHTV. The data included inflammatory and metabolic profile, personal  history and chronic medication. Results: Eighty nine patients were included, 38.2% women and 61.8% men, with a mean age of 73.23 years ± 16.26. 29.2% patients had a previous diabetes diagnosis, 53.4% hypertension and 29.5% cardiac insufficiency. The overall mortality was 14.6%, 7.86% of the patients were admitted to the iIntensive Care Unit and there were no significant  differences between the  groups (diabetic versus non-diabetic). The average HbA1C was 6.96% and there was a positive and significant correlation between the blood glucose values and lactate, C-reactive protein and leukocyte values. Conclusion: Higher blood glucose levels at ED admission appear to be associated with more severe inflammatory states and may also explain some of the variance in lactate and leukocyte values. The diabetic population had good metabolic control, which may clarify the absence of significant differences in severity and mortality between groups.

Palabras clave : COVID-19; Diabetes Mellitus; Infecções por Coronavírus; Coronavirus Infections; COVID-19; Diabetes Mellitus.

        · resumen en Portugués     · texto en Portugués     · Portugués ( pdf )